Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

BACKGROUND: Because sunitinib can induce extensive necrosis in metastatic renal cell cancer (mRCC), we examined whether criteria defined by Choi might be valuable to predict early sunitinib efficacy. METHODS: Computed tomography was used for measurement of tumour lesions in mm and lesion attenuation...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Veldt, A A M, Meijerink, M R, van den Eertwegh, A J M, Haanen, J B A G, Boven, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833256/
https://www.ncbi.nlm.nih.gov/pubmed/20145618
http://dx.doi.org/10.1038/sj.bjc.6605567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833256/
https://www.ncbi.nlm.nih.gov/pubmed/20145618
http://dx.doi.org/10.1038/sj.bjc.6605567

Ejemplares similares